WednesdayMar 09, 2022 12:54 pm

Researchers Discover Disordered Alcohol Use Leads to Poor Functional Brain Connectivity

A recently published study has found that modified neural activity patterns may compromise the ability of some individuals to interpret facial expressions. The researchers found that individuals predisposed to alcohol problems and heavy drinking may have altered signaling patterns in regions of the brain that process social situations and emotions. In their report, the researchers explained that differences in brain connectivity could help forecast future alcohol use for an individual as well as offer the basis for new interventions for the prevention and treatment of alcohol use disorder. The risk of developing alcohol use problems has been linked to a…

Continue Reading

WednesdayMar 09, 2022 9:30 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Updates Recent Product Diversification Efforts and Strategic Acquisitions Developments; Announces VP Of Sales & Marketing Appointment

In a recent update, InMed Pharmaceuticals president and CEO, Eric A. Adams, lauded the company’s progress and achievements so far, particularly with its product diversification and strategic acquisitions  Adams noted the company’s commitment to launching more products and executing more programs to continue growing its product portfolio  InMed also announced the appointment of Gerald (“Jerry”) P. Griffin III as Vice President of Sales and Marketing at BayMedica, its wholly-owned subsidiary In a conference call and webcast on February 15, 2022, Eric A. Adams, President and Chief Executive Officer of InMed Pharmaceuticals (NASDAQ: INM), emphasized the company’s successful product diversification and…

Continue Reading

TuesdayMar 08, 2022 3:25 pm

National Brain Tumor Society, Yale Collaborate to Form DNA Damage Response Consortium

The National Brain Tumor Society and Yale University have partnered to conduct research on response mechanisms for DNA damage in an attempt to find new treatments for brain tumor patients. The National Brain Tumor Society is the biggest not-for-profit organization focused on brain cancer in the United States. The initiative, called the DNA Damage Response Consortium, will be led by Professor Ranjit Bindra of the School of Medicine at Yale University. Bindra is the scientific director of the Chênevert Brain Tumor Center, in addition to being a professor of therapeutic radiology. In an interview, Bindra explained that the damage response…

Continue Reading

MondayMar 07, 2022 12:40 pm

New Study Finds That Family Members of Patients with Severe COVID Infections May Suffer PTSD

A new study has found that family members of individuals who have been hospitalized in the ICU due to coronavirus infections may suffer from PTSD in comparison with family members of patients with acute respiratory distress syndrome caused by other ailments. The study, which was conducted by French researchers, reported its findings in “JAMA Network.” For their study, the researchers carried out a prospective cohort study in 23 intensive care units in France between January and June 2020, with a final follow-up being conducted that same year in October. Family members of individuals with and survivors of acute respiratory distress…

Continue Reading

MondayMar 07, 2022 11:15 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Gives Corporate Presentation, Q&A Session at Virtual Investor 2022 Top Picks Conference

The company also participated in the H.C. Wainwright BioConnect Conference earlier in January CNS Pharmaceuticals recently received approval from swissethics for a pivotal Berubicin and GBM clinical trial The five-year survival rate for GBM is only 6.8%, with the average patient population surviving 12 to 18 months after diagnosis CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, recently participated in the Virtual Investor 2022 Top Picks Conference. During the event, CEO John Climaco provided a corporate presentation and then participated in a…

Continue Reading

MondayMar 07, 2022 11:00 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), Chopra Foundation Partner in Efforts to Support Progress Toward Psychedelic-Based Therapeutics

Psychedelic drugs are on cusp of entering mainstream treatment for mental illness Cybin, Chopra Foundation to collaborate on efforts aimed to support education, awareness about psychedelic therapy mental health research Cybin “one of the only companies that may truly address the needs of patients and providers,” says Dr. Deepak Chopra A significant increase in research and growing public support are key indicators of the future of psychedelics, which are “on the cusp of entering mainstream psychiatry,” according to a recent “New York Times” article (https://ibn.fm/GshwS). Another strong indicator of the future of psychedelics is the exciting partnership just announced by…

Continue Reading

FridayMar 04, 2022 9:30 am

Study Finds That Walkable Neighborhoods Decrease Prevalence of Diabetes, Obesity

A new study has found that individuals living in neighborhoods having access to outdoor activities and parks have a reduced chance of suffering from obesity or diabetes because the neighborhood residents are  more active. Data shows that more than 11% of the U.S. population has diabetes with almost one-half of adults also suffering from obesity. Gillian L. Booth, colead author of the study, stated that the built environment influenced the levels of physical activity an individual undertook, through the promotion of active forms of transportation, such as cycling and walking, over passive ones, such as driving a car. The built…

Continue Reading

ThursdayMar 03, 2022 9:30 am

Researchers Uncover Why Naked Mole Rats Live Long

A new study has found that naked mole rats demonstrate exceptional resistance to cancer and aging. Naked mole rats have long interested researchers involved in cancer research and aging research. Recently, researchers from the Kumamoto University in Japan succeeded in isolating stem cells from the brains of these rodents. In their report, the researchers explained how these cells helped maintain body homeostasis, which is important in cancer resistance and aging. Cancer and aging is caused by the depletion and dysfunction of tissue-specific stem cells, which are cells that differentiate to form specialized cells. These cells were found throughout the bodies…

Continue Reading

ThursdayMar 03, 2022 9:00 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Granted U.S. Patent for Deuterated DMT

Company announced the first officially issued patent Patent provides strong protection for Cybin’s growing IP portfolio of psychedelic-based compounds CYB004 has demonstrated potential efficacy at lower doses while increasing duration of drug effect that may alleviate common negative experiences In a milestone moment for psychedelic therapeutics company Cybin (NEO: CYBN) (NYSE American: CYBN), the company has announced its first official issued patent. The U.S. Patent and Trademark Office (“USPTO”) has granted U.S. patent 11,242,318 to Cybin’s proprietary CYB004, the company’s lead investigational proprietary DMT compound. “From the outset, Cybin has focused on creating differentiated compounds that harness the potential efficacy of…

Continue Reading

WednesdayMar 02, 2022 9:30 am

Researchers to Study Why Music, Art Therapy Benefits Mental Health Patients

The National Endowment for the Arts is sponsoring an arts therapy initiative known as Creative Forces in partnership with the Department of Veterans Affairs and Department of Defense. Art therapies are increasingly being used to treat various brain conditions, including Alzheimer’s, Parkinson’s disease, depression and post-traumatic stress disorder. However, most of these therapies, ranging from poetry to music to visual arts, haven’t undergone exhaustive scientific testing. Brain researchers and artists have started an initiative called the NeuroArts Blueprint to conduct research into this. The initiative is the result of collaboration between the Aspen Institute’s Health, Medicine and Society Program, and…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000